HIV-1 Tat protein trans-activates transcription in vitro.
about
Tat-SF1 protein associates with RAP30 and human SPT5 proteinsThe cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNAA cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionCA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcriptionCloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifsThe type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genesRole of flanking E box motifs in human immunodeficiency virus type 1 TATA element functionCharacterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitroPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequencesSp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat proteinHuman immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complexNovel mechanism and factor for regulation by HIV-1 TatThe HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factorSynergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsFunctional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeatIn vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factorInteractions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivatorIn vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAPLentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactorInteraction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complexMutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarlyThe human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for functionHIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFsNormal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain proteinStructure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulgeTat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replicationAssociation of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexesA novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitroThe Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKRThe human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoterInhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitroP-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitroParental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BCMechanisms of HIV-1 to escape from the host immune surveillance.Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from ThailandRetroviruses and cancer: models for cancer in animals and humans.Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase.Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat
P2860
Q22003803-B8A705C3-44FD-4F87-9147-F28956EA7935Q24312742-250133C8-28B9-4390-AE1F-90B351229EA4Q24314052-F00F5DE8-DD03-468C-B9C7-5BAFD7760486Q24315725-3820C124-6090-4972-98BD-E0F79F220B3EQ24317451-8CCB61C6-F1A9-49B6-9C9C-3F7AAA0C1580Q24319734-0FA99E33-F806-4758-A27E-3752CBBFF94AQ24324023-A495BBAA-B23D-43AF-B177-401597EDD977Q24324378-C32262F8-8965-44BD-9207-992EBE718E1AQ24523183-8522E003-CDFB-4AD6-8EE0-82850C7F9378Q24537527-99AD860C-B7E6-402B-B996-3962C966339FQ24561778-65AFF37E-91AA-42D1-93A0-9A44A44A8831Q24568316-F6D5E40F-4EF5-4641-9112-C0F4ACC62349Q24568366-A7458AA0-E116-4A45-8475-553BFF0997CDQ24596637-6F2019AF-44F8-4A55-8BF6-31EE39C83500Q24644981-1FB78F4B-8C1F-4D93-8805-F6758E2DA90DQ24651506-A053C7AE-A385-4C29-AD35-8D03C3D7D399Q24655684-47159B0E-9E67-4831-BD3B-F86298C163D1Q24655901-DC9455BB-7CCB-47AF-9382-B6712B9F8095Q24671522-C849B474-FACD-43AD-BDB2-D958491FE891Q24675459-A0CA4A48-C9E9-4398-8757-845FDF64102DQ24676286-AEF378ED-4B2E-456F-9923-A3D5671E825AQ24681921-80B5857C-CE58-41A2-A412-F75306EA293DQ24682057-87CA6F62-FC9A-4E69-8989-C87550410A09Q24682531-EEAFF6B0-01FE-4159-ABF8-6E9AD28347CBQ24797317-E8BA89E1-E24E-40A9-B1EF-F6B10D76B4ADQ24810079-A17D49B4-24CC-4248-9855-FB81A3C47FD3Q27733920-2A3513EA-9E32-42C1-8B56-37560AC8CA37Q28214887-AA550CF4-42AD-44BB-9EF2-B091367F5ED3Q28304889-32137CB9-AABF-4BFE-82B9-A5564A23F26DQ28306373-14D2B9F8-033A-4F7F-A5CD-7EBD543D9F39Q28306498-73FA1E5A-38E7-4DFE-A1CA-A616CCD5E2CEQ28368856-5A6AF68B-6E43-42F4-9B01-B0B79C43A35AQ28378556-695159C3-A182-47FC-B464-8605AFCE7916Q28379179-463072BC-C72B-4F75-B192-8D63326CFA35Q28480941-4A6A41FC-B180-4379-BD4D-998543325164Q30327140-53D782AF-F3BF-4692-8AB0-E87F0ACEDA8FQ30424377-99451B59-F96B-4A54-8587-C3E8D14E61B7Q30467457-5F39AF98-3182-4436-8534-152AA4323631Q31807459-45517905-07A1-422C-AA54-AFD626934C0FQ33728518-E4DF114E-09B9-49EF-BF45-052FBD88026B
P2860
HIV-1 Tat protein trans-activates transcription in vitro.
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
HIV-1 Tat protein trans-activates transcription in vitro.
@ast
HIV-1 Tat protein trans-activates transcription in vitro.
@en
type
label
HIV-1 Tat protein trans-activates transcription in vitro.
@ast
HIV-1 Tat protein trans-activates transcription in vitro.
@en
prefLabel
HIV-1 Tat protein trans-activates transcription in vitro.
@ast
HIV-1 Tat protein trans-activates transcription in vitro.
@en
P2093
P1433
P1476
HIV-1 Tat protein trans-activates transcription in vitro.
@en
P2093
Frankel AD
Marciniak RA
P304
P356
10.1016/0092-8674(90)90145-5
P407
P577
1990-11-01T00:00:00Z